Cash T - Search Results

1

The role of position 4 in angiotensin II antagonism: a structure-activity study.

Samanen J, Cash T, Narindray D, Brandeis E, Yellin T, Regoli D. Samanen J, et al. Among authors: cash t. J Med Chem. 1989 Jun;32(6):1366-70. doi: 10.1021/jm00126a037. J Med Chem. 1989. PMID: 2724307

2

An investigation of angiotensin II agonist and antagonist analogues with 5,5-dimethylthiazolidine-4-carboxylic acid and other constrained amino acids.

Samanen J, Cash T, Narindray D, Brandeis E, Adams W Jr, Weideman H, Yellin T, Regoli D. Samanen J, et al. Among authors: cash t. J Med Chem. 1991 Oct;34(10):3036-43. doi: 10.1021/jm00114a012. J Med Chem. 1991. PMID: 1920354

3

Potent angiotensin II antagonists with non-beta-branched amino acids in position 5.

Samanen J, Narindray D, Cash T, Brandeis E, Adams W Jr, Yellin T, Eggleston D, DeBrosse C, Regoli D. Samanen J, et al. Among authors: cash t. J Med Chem. 1989 Feb;32(2):466-72. doi: 10.1021/jm00122a030. J Med Chem. 1989. PMID: 2913307

4

Effects of D-amino acid substitution on antagonist activities of angiotensin II analogues.

Samanen J, Narindray D, Adams W Jr, Cash T, Yellin T, Regoli D. Samanen J, et al. Among authors: cash t. J Med Chem. 1988 Mar;31(3):510-6. doi: 10.1021/jm00398a005. J Med Chem. 1988. PMID: 3346871

5

The importance of residues 2 (arginine) and 6 (histidine) in high-affinity angiotensin II antagonists.

Samanen J, Brandeis E, Narindray D, Adams W, Cash T, Yellin T, Regoli D. Samanen J, et al. Among authors: cash t. J Med Chem. 1988 Apr;31(4):737-41. doi: 10.1021/jm00399a008. J Med Chem. 1988. PMID: 3351849

6

Regulation of B-Raf kinase activity by tuberin and Rheb is mammalian target of rapamycin (mTOR)-independent.

Karbowniczek M, Cash T, Cheung M, Robertson GP, Astrinidis A, Henske EP. Karbowniczek M, et al. Among authors: cash t. J Biol Chem. 2004 Jul 16;279(29):29930-7. doi: 10.1074/jbc.M402591200. Epub 2004 May 18. J Biol Chem. 2004. PMID: 15150271 Free article.

7

Tuberin, the tuberous sclerosis complex 2 tumor suppressor gene product, regulates Rho activation, cell adhesion and migration.

Astrinidis A, Cash TP, Hunter DS, Walker CL, Chernoff J, Henske EP. Astrinidis A, et al. Oncogene. 2002 Dec 5;21(55):8470-6. doi: 10.1038/sj.onc.1205962. Oncogene. 2002. PMID: 12466966

8

The role of the Birt-Hogg-Dubé protein in mTOR activation and renal tumorigenesis.

Hartman TR, Nicolas E, Klein-Szanto A, Al-Saleem T, Cash TP, Simon MC, Henske EP. Hartman TR, et al. Among authors: cash tp. Oncogene. 2009 Apr 2;28(13):1594-604. doi: 10.1038/onc.2009.14. Epub 2009 Feb 23. Oncogene. 2009. PMID: 19234517 Free PMC article.

9

Loss of the Birt-Hogg-Dubé tumor suppressor results in apoptotic resistance due to aberrant TGFβ-mediated transcription.

Cash TP, Gruber JJ, Hartman TR, Henske EP, Simon MC. Cash TP, et al. Oncogene. 2011 Jun 2;30(22):2534-46. doi: 10.1038/onc.2010.628. Epub 2011 Jan 24. Oncogene. 2011. PMID: 21258407 Free PMC article.

10

Hypoxia-induced energy stress regulates mRNA translation and cell growth.

Liu L, Cash TP, Jones RG, Keith B, Thompson CB, Simon MC. Liu L, et al. Mol Cell. 2006 Feb 17;21(4):521-31. doi: 10.1016/j.molcel.2006.01.010. Mol Cell. 2006. PMID: 16483933 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

177 results

Search Page

Filters